• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • France

Cathay leads €30m funding round for Echosens

  • José Rojo
  • José Rojo
  • 30 April 2015
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Cathay Capital Private Equity has led a €30m financing round for French hepatology diagnostic business Echosens alongside OrbiMed Advisors and a private Chinese fund.

Previously holding a 99.46% stake in Echosens, Chinese parent company FuRui Medical will now retain a 51% shareholding in the business. The trio of investors will hold the remaining 49%, with Cathay securing a significant portion of the stake.

The funding round marks the first investment by Cathay's Sino French Midcap fund. Launched by the mid-market GP in June 2014, the vehicle reached its €500m hard-cap when it held a final close six months later, according to unquote" data.

Echosens

  • DEAL:

    Expansion

  • VALUE:

    €30m est.

  • LOCATION:

    Paris

  • SECTOR:

    Medical equipment

  • FOUNDED:

    2001

The buyout fund's commitments came from around 30 LPs. BPI France and China Development Bank were cornerstone investors, contributing €100m each to the capital pool.

Targeting an average €15-50m for its investments, Sino French Midcap plans to make 40% of its investments in France, 40% in China, while the remaining 20% will be distributed across Europe, with an emphasis on Germany.

Echosens aims to use the capital increase to bolster its international expansion, specifically across the North American and Chinese markets.

The liver diagnosis services provider also plans to make targeted acquisitions in the medical technologies sector in order to strengthen its worldwide distribution network.

The funding round marks the fourth investment in a French healthcare company in the past two months, following Ace Management and Auriga Partners' investment in phagotherapy developer Pherecydes Farma's €2.6m round. Meanwhile, London-based MML Capital Partners backed ophthalmology equipment supplier Luneau Technology.

Company
Founded in 2001, Echosens specialises in liver disease diagnosis. The Paris-headquartered business develops medical devices that incorporate vibration-controlled transient elastography technology. The company's product range includes FibroScan, a non-invasive fibrosis and steatosis diagnosis solution used in 70 countries.

People
Cathay Capital Private Equity was represented by president Mingpo Cai. Guanyi Wang is president at FuRui Medical and Claude Lenoir is CEO at Echosens.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • France
  • Expansion
  • Healthcare
  • France
  • Cathay Capital

More on France

EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
EU foreign subsidies regulations
EU FSR could impact PE fundraising with potential rise in ‘clean funds’

FSR could lead GPs to create funds without foreign LPs; red tape around sovereign wealth funds likely

  • Regulation
  • 01 September 2023
Mergermarket
Letter from the editor: Unquote is moving to Mergermarket

Unquote Editor Harriet Matthews outlines Unquote.com's upcoming move to the Mergermarket platform and the new capabilities and intelligence that this brings to Unquote readers

  • Industry
  • 30 August 2023
Pensions administration software providers
IK Investment-backed Eres expected to hit the auction block by 2024

French employee savings distribution and management firm could be valued at a few hundred million euros

  • Exits
  • 24 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013